CF Industries Operating Cash Flow decreased by 8.0% to $496.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $586.00M to $496.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows relatively stable performance with a -1.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $128.00M | $687.00M | $1.48B | $1.39B | $889.00M | $990.00M | $585.00M | $947.00M | $712.00M | $618.00M | $480.00M | $445.00M | $475.00M | $931.00M | $420.00M | $586.00M | $563.00M | $1.06B | $539.00M | $496.00M |
| QoQ Change | — | +436.7% | +115.4% | -6.0% | -36.1% | +11.4% | -40.9% | +61.9% | -24.8% | -13.2% | -22.3% | -7.3% | +6.7% | +96.0% | -54.9% | +39.5% | -3.9% | +89.0% | -49.3% | -8.0% |
| YoY Change | — | — | — | — | +594.5% | +44.1% | -60.5% | -31.9% | -19.9% | -37.6% | -17.9% | -53.0% | -33.3% | +50.6% | -12.5% | +31.7% | +18.5% | +14.3% | +28.3% | -15.4% |